Description of the medicine: Nizatidine (Nizatidine)
N- [2 - [[[2 - [(Dimethylamino) methyl] -4-thiazolyl] methyl] thio] ethyl] -Nґ-methyl-2-nitro-1,1-ethylenediamine.
Synonym: Axid, Axid.
By structure and action is close to famotidine (see).
Quickly and almost completely absorbed in the digestive tract, bioavailability is 70%, C max - S-3 h, T S - 1-2 h; Is excreted mainly with urine in an unchanged form.
Assign with peptic ulcer of the stomach and duodenum, with reflux-esophagitis, pancreatitis, bleeding from the upper gastrointestinal tract.
Apply inside and intravenously.
Inside appoint adults to 0.15 g 2 times a day (morning and evening) or 0.3 grams 1 time per day; For prophylaxis - 0.15 g once a day.
Intravenously enter 0.1 g bolus 3 times a day or drip at a rate of 0.01 g per hour.
Possible side effects: a violation of the liver, drowsiness, gynecomastia, anemia, thrombocytopenia, urticaria.
The drug is contraindicated in pregnancy, breast-feeding and in childhood.
Form release: capsules of 0.15 and 0.3 grams (N. 14, 28); 2.5% solution for injection in ampoules of 4 ml.
Storage: List B.